Peripheral blood cytotoxic lymphocyte gene transcript levels differ in patients with long-term type 1 diabetes compared to normal controls

Dongmei Han, Jenifer Leith, Rodolfo Alejandro, Wade Bolton, Camillo Ricordi, Norma S Kenyon

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The purpose of this study was to compare mRNA levels of the cytotoxic lymphocyte (CL) gene products: granzyme B (GB), perform (P), and fas ligand (FasL) in patients with long-term type 1 diabetes and healthy controls. The objective was to utilize this information to follow patients as they undergo islet cell transplantation at our center and to determine if changes in CL gene transcript levels correlate with graft status. We have measured mRNA levels for CL genes in peripheral blood samples from 65 long-term (>5 years) type 1 diabetes patients and 29 healthy controls. Total RNA was extracted from EDTA anticoagulated peripheral blood samples and reverse transcribed into first-strand cDNA using Superscript II reverse Transcriptase. Quantitative, real-time PCR was utilized to determine CL gene transcript levels. mRNA levels of P and FasL genes were found to be significantly lower for patients with type 1 diabetes compared to normal controls (p < 0.05). However, there was no significant difference for GB mRNA levels between patients and controls (p > 0.05). The decreased expression of P and FasL in patients with long-term type 1 diabetes might contribute to the inability to maintain normal levels of peripheral tolerance, which is essential for protection from autoimmune disease.

Original languageEnglish
Pages (from-to)403-409
Number of pages7
JournalCell Transplantation
Volume14
Issue number6
StatePublished - Sep 27 2005

Fingerprint

Lymphocytes
Medical problems
Type 1 Diabetes Mellitus
Blood
Genes
Fas Ligand Protein
Ligands
Messenger RNA
Peripheral Tolerance
Granzymes
Islets of Langerhans Transplantation
RNA-Directed DNA Polymerase
Cell Transplantation
Ethylenediaminetetraacetic acid
RNA
Islets of Langerhans
Grafts
Edetic Acid
Autoimmune Diseases
Real-Time Polymerase Chain Reaction

Keywords

  • Cytotoxic lymphocyte genes
  • Fas ligand
  • Granzyme B
  • Perforin
  • Peripheral blood
  • Type 1 diabetes

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation

Cite this

Peripheral blood cytotoxic lymphocyte gene transcript levels differ in patients with long-term type 1 diabetes compared to normal controls. / Han, Dongmei; Leith, Jenifer; Alejandro, Rodolfo; Bolton, Wade; Ricordi, Camillo; Kenyon, Norma S.

In: Cell Transplantation, Vol. 14, No. 6, 27.09.2005, p. 403-409.

Research output: Contribution to journalArticle

@article{5a4ea0f784ce414c8ba78ebb0e26e321,
title = "Peripheral blood cytotoxic lymphocyte gene transcript levels differ in patients with long-term type 1 diabetes compared to normal controls",
abstract = "The purpose of this study was to compare mRNA levels of the cytotoxic lymphocyte (CL) gene products: granzyme B (GB), perform (P), and fas ligand (FasL) in patients with long-term type 1 diabetes and healthy controls. The objective was to utilize this information to follow patients as they undergo islet cell transplantation at our center and to determine if changes in CL gene transcript levels correlate with graft status. We have measured mRNA levels for CL genes in peripheral blood samples from 65 long-term (>5 years) type 1 diabetes patients and 29 healthy controls. Total RNA was extracted from EDTA anticoagulated peripheral blood samples and reverse transcribed into first-strand cDNA using Superscript II reverse Transcriptase. Quantitative, real-time PCR was utilized to determine CL gene transcript levels. mRNA levels of P and FasL genes were found to be significantly lower for patients with type 1 diabetes compared to normal controls (p < 0.05). However, there was no significant difference for GB mRNA levels between patients and controls (p > 0.05). The decreased expression of P and FasL in patients with long-term type 1 diabetes might contribute to the inability to maintain normal levels of peripheral tolerance, which is essential for protection from autoimmune disease.",
keywords = "Cytotoxic lymphocyte genes, Fas ligand, Granzyme B, Perforin, Peripheral blood, Type 1 diabetes",
author = "Dongmei Han and Jenifer Leith and Rodolfo Alejandro and Wade Bolton and Camillo Ricordi and Kenyon, {Norma S}",
year = "2005",
month = "9",
day = "27",
language = "English",
volume = "14",
pages = "403--409",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "6",

}

TY - JOUR

T1 - Peripheral blood cytotoxic lymphocyte gene transcript levels differ in patients with long-term type 1 diabetes compared to normal controls

AU - Han, Dongmei

AU - Leith, Jenifer

AU - Alejandro, Rodolfo

AU - Bolton, Wade

AU - Ricordi, Camillo

AU - Kenyon, Norma S

PY - 2005/9/27

Y1 - 2005/9/27

N2 - The purpose of this study was to compare mRNA levels of the cytotoxic lymphocyte (CL) gene products: granzyme B (GB), perform (P), and fas ligand (FasL) in patients with long-term type 1 diabetes and healthy controls. The objective was to utilize this information to follow patients as they undergo islet cell transplantation at our center and to determine if changes in CL gene transcript levels correlate with graft status. We have measured mRNA levels for CL genes in peripheral blood samples from 65 long-term (>5 years) type 1 diabetes patients and 29 healthy controls. Total RNA was extracted from EDTA anticoagulated peripheral blood samples and reverse transcribed into first-strand cDNA using Superscript II reverse Transcriptase. Quantitative, real-time PCR was utilized to determine CL gene transcript levels. mRNA levels of P and FasL genes were found to be significantly lower for patients with type 1 diabetes compared to normal controls (p < 0.05). However, there was no significant difference for GB mRNA levels between patients and controls (p > 0.05). The decreased expression of P and FasL in patients with long-term type 1 diabetes might contribute to the inability to maintain normal levels of peripheral tolerance, which is essential for protection from autoimmune disease.

AB - The purpose of this study was to compare mRNA levels of the cytotoxic lymphocyte (CL) gene products: granzyme B (GB), perform (P), and fas ligand (FasL) in patients with long-term type 1 diabetes and healthy controls. The objective was to utilize this information to follow patients as they undergo islet cell transplantation at our center and to determine if changes in CL gene transcript levels correlate with graft status. We have measured mRNA levels for CL genes in peripheral blood samples from 65 long-term (>5 years) type 1 diabetes patients and 29 healthy controls. Total RNA was extracted from EDTA anticoagulated peripheral blood samples and reverse transcribed into first-strand cDNA using Superscript II reverse Transcriptase. Quantitative, real-time PCR was utilized to determine CL gene transcript levels. mRNA levels of P and FasL genes were found to be significantly lower for patients with type 1 diabetes compared to normal controls (p < 0.05). However, there was no significant difference for GB mRNA levels between patients and controls (p > 0.05). The decreased expression of P and FasL in patients with long-term type 1 diabetes might contribute to the inability to maintain normal levels of peripheral tolerance, which is essential for protection from autoimmune disease.

KW - Cytotoxic lymphocyte genes

KW - Fas ligand

KW - Granzyme B

KW - Perforin

KW - Peripheral blood

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=24944576026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944576026&partnerID=8YFLogxK

M3 - Article

C2 - 16180659

AN - SCOPUS:24944576026

VL - 14

SP - 403

EP - 409

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 6

ER -